S100A11 promotes TGF-β1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma

Future Oncol. 2018 Apr;14(9):837-847. doi: 10.2217/fon-2017-0534. Epub 2018 Mar 23.

Abstract

Aim: Our previous study found S100A11 was significantly raised in intrahepatic cholangiocarcinoma cells, but the relationship between S100A11 and intrahepatic cholangiocarcinoma remains unclear.

Methods: We investigated the effect of silencing S100A11 on TGF-β1-induced epithelial-mesenchymal transition (EMT), cell migration and invasion.

Results: Our results demonstrated silencing S100A11 inhibited TGF-β1-induced cell migration, invasion and EMT, expression of EMT markers E-cadherin, N-cadherin, β-catenin, vimentin, Slug and Snail was reversed. Furthermore, TGF-β1-induced p-SMAD2 and 3 were also inhibited due to low S100A11 expression.

Conclusion: Our present study indicated that S100A11 promotes EMT through accumulation of TGF-β1 expression, and TGF-β1-induced upregulation of p-SMAD2 and 3.

Keywords: EMT; intrahepatic cholangiocarcinoma; invasion.

MeSH terms

  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cholangiocarcinoma / genetics*
  • Cholangiocarcinoma / pathology
  • Epithelial-Mesenchymal Transition / genetics
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasm Invasiveness / genetics
  • Neoplasm Invasiveness / pathology
  • Neoplasm Proteins / genetics
  • S100 Proteins / genetics*
  • Signal Transduction
  • Smad2 Protein / genetics*
  • Smad3 Protein / genetics
  • Transforming Growth Factor beta1 / genetics*

Substances

  • Neoplasm Proteins
  • S100 Proteins
  • Smad2 Protein
  • Smad3 Protein
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • S100A11 protein, human